Presentation title 09/11/08 balancing cost vs. corporate green responsiblity
Slide no 209/11/08 Who is Novo Nordisk? Healthcare company headquartered in Denmark. World leader in diabetes care. Also have leading positions in hemostasis management, growth hormone therapy, and hormone replacement therapy. US headquarters in Princeton, NJ.
Slide no 309/11/08 Our Triple Bottom Line Philosophy
Slide no 409/11/08 So, how does this apply to our fleet?
Slide no 509/11/08 For Novo Nordisk, an environmentally friendly fleet contains vehicles that: meet the job needs of our drivers (can carry all materials needed) are fuel efficient reduce the company’s carbon footprint as stated in our goals (5%/year for next 5 years) stay within budgetary guidelines are safe for our drivers are easy to drive and maintain may or may not meet the driver’s family needs as long as it meets their job requirements
Slide no 609/11/08 An environmentally friendly fleet can contain a mixture of: 4-cylinder engine vehicles hybrid vehicles alternative fuel vehicles (E85, bio-diesel, etc.) best-in-class mpg rated vehicles for SUVs, minivans, etc.
Slide no 709/11/08 In addition to vehicles, an environmentally friendly fleet contains drivers who: Have been informed/trained on how to drive to reduce emissions and conserve fuel. Are committed to reducing greenhouse gases and willing to work toward achieving environmental sustainability.
Slide no 809/11/08 What is Novo Nordisk doing? Set goal to reduce carbon footprint by 5% each year for next 5 years for total reduction of 25% by Included hybrids, 4-cylinder sedans, and more fuel efficient vehicles on selectors. Monitor drivers’ gas usage for out of policy issues. Required all drivers to take a “Driving Green” module on-line Other recommendations include: going back to only offering 4-wheel drive vehicles to Snowbelt drivers creating separate Level 1 selectors (rep level) to more closely match job needs
Slide no 909/11/08 Problems Encountered Availability of hybrids from manufacturers Continued poor perception of 4-cylinder engines by drivers Company’s desire to provide “better” selector than other pharma companies—hesitant to remove SUV’s and minivans. Drivers are conflicted between “doing the right thing” and getting the type of vehicle they really want!
Slide no 1009/11/08 Solutions Make small changes – baby steps still get results. Constant communication to drivers How are we doing vs. our goals Who’s making a difference Information on environmental issues/what they can do to help Constant education of upper level management Keep up with current/future trends, products, developments, etc.